Compound Summary


erythromycin
  Compound Information
 erythromycin

Compound Name:

erythromycin

Compound CID:

12560

Synonyms:

erythromycin

114-07-8

Erythromycin A

E-Mycin

Erythrocin

More...

Iupac Name:

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

InChI:

InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1

InChIKey:

ULGZDMOVFRHVEP-RWJQBGPGSA-N

Canonical Smiles:

CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O

Isomeric Smiles:

CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O

Molecular Weight:

733.9

Molecular Formula:

C37H67NO13

  Compound Structure
 2D Structure:
 3D Structure:
  Computed Properties
 erythromycin

Molecular Weight:

733.9

Molecular Formula:

C37H67NO13

Hydrogen Bond Donor Count:

5

Hydrogen Bond Acceptor Count:

14

Rotatable Bond Count:

7

Heavy Atom Count:

51

Complexity:

1180

  Synonyms
 erythromycin

erythromycin erythromycin

erythromycin

114-07-8

Erythromycin A

E-Mycin

Erythrocin

Abomacetin

Ilotycin

Erythromycinum

Erymax

Emgel

Eritromicina

Erythromycine

Erythro-Statin

Erythromycin base

E-Glades

Ery-Tab

E-Base

Eryacne

ERYTHROMYCIN STEARATE

Torlamicina

Erycette

Robimycin

Bristamycin

Erypar

erythro

Erythroguent

Eritrocina

Stiemycin

Ermycin

Erycen

Erygel

Aknin

ERYC

Pfizer-E

(-)-ERYTHROMYCIN

Theramycin Z

Erythrocin stearate

Ak-Mycin

Erythromast 36

T-Stat

Benzamycin

MFCD00084654

Emycin

Erytab

Inderm

Retcin

UNII-63937KV33D

CHEMBL532

erythromycin-A

Dumotrycin

Mephamycin

CHEBI:42355

Sansac

Wemid

Eryc Sprinkles

Erythra-Derm

A/T/S

Akne-Mycin

63937KV33D

R-P Mycin

Endoeritrin

Eritomicina

Erythroderm

Erytrociclin

Paediathrocin

Pharyngocin

Proterytrin

Acneryne

Acnesol

Aknemycin

Derimer

Deripil

Erisone

Eryacnen

Erydermer

Eryhexal

Erysafe

Iloticina

Latotryd

Lederpax

Mercina

Oftamolets

Pantoderm

Pantodrin

Primacine

Romycin

Stiemicyn

Tiloryth

Tiprocin

E-Solve 2

Emuvin

Erecin

Erymed

Erytop

NCI-C55674

AustriaS

Eros

Ery-maxin

Erythro-Teva

Sans-acne

DSSTox_CID_2991

Erimycin-T

Ery-Diolan

Inderm Gel

Del-Mycin

Aknederm Ery Gel

Udima Ery Gel

Eryc 125

UNII-8HPH7ND0LN

DSSTox_RID_76820

DSSTox_GSID_22991

Emu-Ve

8HPH7ND0LN

Skid Gel E

(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)oxacyclotetradecane-2,10-dione

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione

Akne Cordes Losung

ERY

Ilosone (estolate)

Ilotycin T.S.

E-Mycin (base)

Ery-Tab (base)

Emu-V

Ery-B

E-Base (base)

ERYC (base)

C-Solve-2

N-Methylerythromycin A

PCE Dispertab (base)

Eryc-125

Eryc-250

Eritromicina INN-Spanish

Erythromycine INN-French

Erythromycinum INN-Latin

Oftalmolosa Cusi Eritromicina

Staticin (TN)

Akne-mycin (TN)

Erygel (TN)

Eryc (TN)

T-stat (TN)

Pce (TN)

SR-05000001618

Sentry AQ mardel maracyn

9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

erthromycin

Erythromycines

NSC55929

CCRIS 9078

NSC-55929

HSDB 3074

NCGC00094670-01

Erythromycin USP:INN:BAN:JAN

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yloxy-14-ethyl-7,12,13-trihydroxy-4-(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yloxy-3,5,7,

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy}-14-ethyl-7,12,13-trihydroxy-4-{(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yloxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione

CAS-114-07-8

Prestwick_205

EINECS 204-040-1

Erythromycin C-13

NSC 55929

Spectrum_000115

Spectrum_000659

AI3-50138

EM-A

Prestwick3_000151

Spectrum2_000759

Spectrum2_001263

Spectrum4_000538

Spectrum5_001596

E0751

Erythromycin A, B + C

EC 204-040-1

SCHEMBL2601

BSPBio_000282

BSPBio_002480

Erythromycin standard solution

KBioGR_001175

KBioSS_000555

KBioSS_001139

MLS001066618

BIDD:GT0017

DivK1c_000294

DivK1c_000397

DivK1c_000702

SPECTRUM1500280

SPBio_000778

SPBio_001226

BPBio1_000312

GTPL1456

DTXSID4022991

Erythromycin (JP17/USP/INN)

HMS500O16

KBio1_000294

KBio1_000397

KBio1_000702

KBio2_000555

KBio2_001139

KBio2_003123

KBio2_003707

KBio2_005691

KBio2_006275

J01FA01

Erythromycin (mixture of A,B,C)

NINDS_000294

NINDS_000397

NINDS_000702

HMS1920M04

HMS2091D05

HMS2095O04

HMS3712O04

Pharmakon1600-01500280

ACT03320

HY-B0220

RKL10096

Tox21_111311

Tox21_111869

Tox21_300515

BDBM50344942

CCG-38992

LMPK04000006

NSC756759

ZINC85534336

Erythromycin, labeled with carbon-13

AKOS015895249

DB00199

MCULE-4566208867

NSC-756759

IDI1_000294

IDI1_000397

IDI1_000702

SMP1_000119

NCGC00179619-01

NCGC00179619-02

NCGC00179619-03

NCGC00254234-01

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yloxy-14-ethyl-7,12,13-trihydroxy-4-(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yloxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

82343-12-2

AC-12744

AC-12901

SMR000544946

Erythromycin, potency: >=850 mug per mg

Erythromycin, tested according to Ph.Eur.

SBI-0051368.P003

Erythromycin, N-demethyl-N-(methyl-11C)-

Erythromycin, meets USP testing specifications

C01912

D00140

E-3250

Erythromycin, plant cell culture tested, ~98%

44496-EP2272846A1

44496-EP2275422A1

44496-EP2292608A1

44496-EP2305644A1

44496-EP2308866A1

44496-EP2311814A1

44496-EP2311828A1

44496-EP2380568A1

AB00051981_09

AB00051981_10

Erythromycin standard solution, 1 mg/mL in H2O

Erythromycin, Biotechnology Performance Certified

114E078

Erythromycin estolate impurity, free erythromycin-

Q213511

SR-01000799155

Erythromycin, Antibiotic for Culture Media Use Only

Erythromycin, BioReagent, suitable for cell culture

SR-01000799155-2

SR-05000001618-1

SR-05000001618-2

BRD-K63550407-001-13-5

BRD-K63550407-028-03-9

Erythromycin (mixture of A,B,C) 100 microg/mL in Acetonitrile

Erythromycin A, British Pharmacopoeia (BP) Reference Standard

Erythromycin A, European Pharmacopoeia (EP) Reference Standard

Erythromycin, United States Pharmacopeia (USP) Reference Standard

Erythromycin, for microbiological assay, European Pharmacopoeia (EP) Reference Standard

Erythromycin, Pharmaceutical Secondary Standard; Certified Reference Material

(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-(2,6-Dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribo-hexopyranosyl)oxy-14-ethyl-7,12,13-trihydroxy-3,5,9,11,13-hexamethyl-6-3,4,6-trideoxy-3-

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12,13-trihydroxy-6-3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-tetrahydropyran-2-yloxy-14-ethyl-7,12,13-trihydroxy-4-(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yloxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yloxy-14-ethyl-7,12,13-trihydroxy-4-(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yloxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy}-14-ethyl-7,12,13-trihydroxy-4-{(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yloxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name)

3R-(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxyoxacyclotetradecane-2,10-dione

215031-94-0

  Experimental Data
 erythromycin

Species Dose Unit Control(Avg days) Treatment(Avg days) Avg/Med Lifespan Change(%) Control(Max days) Treatment(Max days) Max Lifespan Change(%) Significant Strain Gender PubMed Avg/Med Lifespan Change tab
Brachionus manjavacas 1.000000000000000 umol/L 42.000000000000000 33.000000000000000 S B. manjavacas 29340835 Active
Brachionus manjavacas 1.000000000000000 umol/L 32.000000000000000 S B. manjavacas 29340835 Active
  Experimental Data Visualization
 erythromycin

  Statistics Data
 erythromycin

Species Avg/Med Lifespan Change(%) Max Lifespan Change(%) Count Reference Count Data point
Brachionus manjavacas 42.000000000000000 33.000000000000000 1 2
  Statistics Data Visualization
 erythromycin